Yahoo Web Search

  1. Ads
    related to FDA
  1. Ex-FDA Chief: Juul Created Teen Vaping Epidemic

    Benzinga via Yahoo FinanceSep 25 16:13 PM

    Just minutes after vaping company Juul announced Wednesday that its CEO Kevin Burns will step down, former FDA Commissioner Dr. Scott Gottlieb told CNBC the company was responsible for ...

  2. The FDA issued a complete response letter to AstraZeneca’s AZN triple-combo inhaler, PT010 while granting approval to Roche’s RHHBY Rituxan to treat pediatric patients two years and older ...

  3. FDA and DEA warn website operators illegally selling opioids

    PR Newswire via Yahoo FinanceSep 30 16:15 PM

    "As the FDA works to forcefully tackle the opioid crisis on all fronts, we cannot allow rogue online pharmacies to continue to fuel the crisis by illegally offering opioids for sale and ...

  4. Roche Holding AG RHHBY announced that the FDA approved the label expansion of Rituxan (rituximab). The agency approved the drug, in combination with glucocorticoids, for the treatment ...

  5. As you know, prior to coming to FDA, I was Director of the NCI, and I'm a long-time cancer doctor. We are here to discuss two top priority issues: first, the ongoing investigation into ...

  6. Abbott Laboratories ABT recently received FDA approval for its Proclaim XR recharge-free neurostimulation system for people with chronic pain. Following the approval, Abbott will be able ...

  7. It was the most significant change to the food safety framework in decades and was an important step that gave the FDA new authorities to help fulfill our obligation to protect consumers ...

  8. IGXT announced that it has resubmitted its new drug application (“NDA”) for Rizaport VersaFilm for the treatment of acute migraines to the FDA. The company received a Complete Response ...

  9. MRK announced that the FDA has accepted its new drug application (NDA) and a supplemental NDA (sNDA) for its antibacterial medicine Dificid (fidaxomicin) to treat Clostridium difficile ...

  10. SILVER SPRING, Md., Sept. 26, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration released a suite of guidances to continue to encourage innovative approaches to the development ...

  1. Ads
    related to FDA